3-[BENZYL-(2-ETHOXYCARBONYL-ETHYL)-AMINO]-PROPIONIC ACID ETHYL ESTER, 95.0%, 250mg

(2S)-2-[[[[3,5-Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N-(diphenylmethyl)-N,3,3-trimethylbutanamide, 97%, 50mg

5-Bromo-2-isobutoxypyrimidine, 1g

(trans,trans)-4'-Propyl-[1,1'-bi(cyclohexan)]-4-ol, 95.0%, 10g

tert-Butyl 2-amino-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-5(6H)-carboxylate hydrochloride, 95%, 1g

3,5-Bis(trifluoromethyl)benzamidoxime, 95.0%, 1g

Danofloxacin, 95.0%, 25mg

Lámina de hafnio 99,5+(exc.Zr) 0,025 x 25 x 25 mm 1 ud

(4R,4'R)-2,2'-(Cyclopropane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 98%, 100mg

9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-2-amino-1,9-dihydro-6h-purin-6-one, 97%, 25g

[2-(Methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide, 95.0%, 25g

(2-Chloroethyl)benzene, 95.0%, 100g

2-[2-(Piperazin-1-yl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione dihydrochloride, 95.0%, 250mg